search subscribe twitter in facebook

Yong Sang Song, MD, PhD.

Dear Colleagues,


I'm delighted to welcome all of you dedicated clinician-scientists at the International Society of Precision Cancer Medicine (ISPCM).

Following the great success of the First First International Conference for Precision Cancer Medicine (ICPCM) in June 2017 in Tokyo, Japan, we decided to launch ISPCM with the wonderful group of cancer researchers in order to meet the urgent needs of the times of individualized cancer prevention and therapy.

No one can deny the fact that we are poised to enter a new era of precision cancer medicine not only in the field of treatment but also diagnosis and prevention. This is absolutely a paradigm shift for cancer research as well as practice. Based on the accumulated knowledge so far, ISPCM will contribute to build a comprehensive knowledge network for biomedical research by incorporating genetic, biochemical, immunologic, and environmental data. This network we will finally make is of definite help to define molecular subtypes of one's cancer and a new taxonomy of cancer which can lead us to effective approaches for cancer cure.

We are holding the ISPCM Annual Meeting to make it a venue for academic exchange among the active cancer researchers. So please share our valuable knowledges, practice patterns, and academic achievements on cancer research. Through the effort and dedication of all members, I truly believe that the ISPCM will play a key role in the scientific advancement of cancer research.

Again, on behalf of the organizers, I would like to express my gratitude to all of you, who have joined this society.

Thank you.